Position in OMER
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,845,888
New position
Shares Held
174,800
first reported quarter
Ownership
0.242%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Prosight Management, LP holds $368,598,367 across 29 Biotechnology names. OMER ranks #21 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NKTR |
Nektar Therapeutics
|
735,000 | $52,883,250 | |
| 2 | JANX |
Janux Therapeutics, Inc.
|
3,550,000 | $49,345,000 | |
| 3 | LKFT |
Lakefront Biotherapeutics NV
|
1,550,000 | $46,500,000 | |
| 4 | STTK |
Shattuck Labs, Inc.
|
5,004,439 | $32,178,542 | |
| 5 | KURA |
Kura Oncology, Inc.
|
3,356,700 | $27,289,971 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
76,000 | $25,146,120 | |
| 7 | MGTX |
MeiraGTx Holdings plc
|
2,629,971 | $22,775,548 | |
| 8 | SNDX |
Syndax Pharmaceuticals Inc
|
770,000 | $17,987,200 |
All Filings in OMER
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,845,888 | 174,800 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||